0001752724-24-167809.txt : 20240729
0001752724-24-167809.hdr.sgml : 20240729
20240729124838
ACCESSION NUMBER: 0001752724-24-167809
CONFORMED SUBMISSION TYPE: NPORT-P
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20240531
FILED AS OF DATE: 20240729
DATE AS OF CHANGE: 20240729
PERIOD START: 20250228
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BNY Mellon ETF Trust
CENTRAL INDEX KEY: 0001493580
ORGANIZATION NAME:
IRS NUMBER: 000000000
STATE OF INCORPORATION: MA
FILING VALUES:
FORM TYPE: NPORT-P
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-23477
FILM NUMBER: 241150475
BUSINESS ADDRESS:
STREET 1: 240 GREENWICH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10286
BUSINESS PHONE: 212-922-6400
MAIL ADDRESS:
STREET 1: 240 GREENWICH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10286
FORMER COMPANY:
FORMER CONFORMED NAME: Dreyfus ETF Trust
DATE OF NAME CHANGE: 20100607
0001493580
S000080184
BNY Mellon Women's Opportunities ETF
C000241888
BNY Mellon Women's Opportunities ETF
BKWO
NPORT-P
1
primary_doc.xml
NPORT-P
false
0001493580
XXXXXXXX
S000080184
C000241888
BNY Mellon ETF Trust
811-23477
0001493580
549300E2C8EQYJ7B0H81
240 Greenwich Street
New York
10286
212-922-6400
BNY Mellon Womens Opportunities ETF
S000080184
549300QAQYJD1TI1DO07
2025-02-28
2024-05-31
N
12576387.89
5355.54
12571032.35
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
UST
Apple Inc
HWUPKR0MPOU8FGXBT394
Apple Inc
037833100
2054.00000000
NS
USD
394881.50000000
3.141201844095
Long
EC
CORP
US
N
1
N
N
N
Alnylam Pharmaceuticals Inc
529900S3ZI14OWRJII50
Alnylam Pharmaceuticals Inc
02043Q107
480.00000000
NS
USD
71246.40000000
0.566750589898
Long
EC
CORP
US
N
1
N
N
N
Eli Lilly & Co
FRDRIPF3EKNDJ2CQJL29
Eli Lilly & Co
532457108
410.00000000
NS
USD
336339.40000000
2.675511371188
Long
EC
CORP
US
N
1
N
N
N
PepsiCo Inc
FJSUNZKFNQ5YPJ5OT455
PepsiCo Inc
713448108
1288.00000000
NS
USD
222695.20000000
1.771494924201
Long
EC
CORP
US
N
1
N
N
N
HubSpot Inc
529900BLNVEW0MVKJB37
HubSpot Inc
443573100
394.00000000
NS
USD
240753.70000000
1.915146610850
Long
EC
CORP
US
N
1
N
N
N
Shopify Inc
549300HGQ43STJLLP808
Shopify Inc
82509L107
4488.00000000
NS
USD
265465.20000000
2.111721556424
Long
EC
CORP
CA
N
1
N
N
N
Pinterest Inc
N/A
Pinterest Inc
72352L106
3204.00000000
NS
USD
132933.96000000
1.057462555969
Long
EC
CORP
US
N
1
N
N
N
Dominion Energy Inc
ILUL7B6Z54MRYCF6H308
Dominion Energy Inc
25746U109
4163.00000000
NS
USD
224468.96000000
1.785604823457
Long
EC
CORP
US
N
1
N
N
N
Trane Technologies PLC
549300BURLR9SLYY2705
Trane Technologies PLC
000000000
848.00000000
NS
USD
277686.08000000
2.208936165851
Long
EC
CORP
IE
N
1
N
N
N
Workday Inc
549300J0DYC0N31V7G13
Workday Inc
98138H101
720.00000000
NS
USD
152244.00000000
1.211069988217
Long
EC
CORP
US
N
1
N
N
N
Zoetis Inc
549300HD9Q1LOC9KLJ48
Zoetis Inc
98978V103
868.00000000
NS
USD
147178.08000000
1.170771627200
Long
EC
CORP
US
N
1
N
N
N
Procter & Gamble Co/The
2572IBTT8CCZW6AU4141
Procter & Gamble Co/The
742718109
1558.00000000
NS
USD
256353.32000000
2.039238408291
Long
EC
CORP
US
N
1
N
N
N
Bright Horizons Family Solutio
N/A
Bright Horizons Family Solutions Inc
109194100
2156.00000000
NS
USD
226638.72000000
1.802864821996
Long
EC
CORP
US
N
1
N
N
N
Microsoft Corp
INR2EJN1ERAN0W5ZP974
Microsoft Corp
594918104
2646.00000000
NS
USD
1098433.98000000
8.737818417912
Long
EC
CORP
US
N
1
N
N
N
Lam Research Corp
549300I4GMO6D34U1T02
Lam Research Corp
512807108
168.00000000
NS
USD
156649.92000000
1.246118183762
Long
EC
CORP
US
N
1
N
N
N
Accenture PLC
5493000EWHDSR3MZWH98
Accenture PLC
000000000
761.00000000
NS
USD
214822.69000000
1.708870711799
Long
EC
CORP
IE
N
1
N
N
N
Akamai Technologies Inc
OC1LZNN2LF5WTJ5RIL89
Akamai Technologies Inc
00971T101
1517.00000000
NS
USD
139928.08000000
1.113099354962
Long
EC
CORP
US
N
1
N
N
N
Caterpillar Inc
WRJR7GS4GTRECRRTVX92
Caterpillar Inc
149123101
420.00000000
NS
USD
142178.40000000
1.131000191881
Long
EC
CORP
US
N
1
N
N
N
Micron Technology Inc
B3DXGBC8GAIYWI2Z0172
Micron Technology Inc
595112103
1757.00000000
NS
USD
219625.00000000
1.747072108998
Long
EC
CORP
US
N
1
N
N
N
JPMorgan Chase & Co
8I5DZWZKVSZI1NUHU748
JPMorgan Chase & Co
46625H100
2252.00000000
NS
USD
456322.76000000
3.629954543868
Long
EC
CORP
US
N
1
N
N
N
Natera Inc
N/A
Natera Inc
632307104
668.00000000
NS
USD
71162.04000000
0.566079523293
Long
EC
CORP
US
N
1
N
N
N
AbbVie Inc
FR5LCKFTG8054YNNRU85
AbbVie Inc
00287Y109
2158.00000000
NS
USD
347955.92000000
2.767918420001
Long
EC
CORP
US
N
1
N
N
N
PTC Inc
54930050SSMU8SKDJ030
PTC Inc
69370C100
658.00000000
NS
USD
115965.92000000
0.922485256352
Long
EC
CORP
US
N
1
N
N
N
Cooper Cos Inc/The
QJKMVPIGLH7530PCUE20
Cooper Cos Inc/The
216648501
1652.00000000
NS
USD
155800.12000000
1.239358197976
Long
EC
CORP
US
N
1
N
N
N
FedEx Corp
549300E707U7WNPZN687
FedEx Corp
31428X106
655.00000000
NS
USD
166343.80000000
1.323231023265
Long
EC
CORP
US
N
1
N
N
N
Bank of America Corp
9DJT3UXIJIZJI4WXO774
Bank of America Corp
060505104
5483.00000000
NS
USD
219265.17000000
1.744209734692
Long
EC
CORP
US
N
1
N
N
N
Schlumberger NV
213800ZUA17OK3QLGM62
Schlumberger NV
806857108
3384.00000000
NS
USD
155291.76000000
1.235314297795
Long
EC
CORP
US
N
1
N
N
N
Mastercard Inc
AR5L2ODV9HN37376R084
Mastercard Inc
57636Q104
784.00000000
NS
USD
350502.88000000
2.788178967656
Long
EC
CORP
US
N
1
N
N
N
Veralto Corp
635400FJE6GSOJUSNY27
Veralto Corp
92338C103
1031.00000000
NS
USD
101635.98000000
0.808493504513
Long
EC
CORP
US
N
1
N
N
N
Edwards Lifesciences Corp
YA13X31F3V31L8TMPR58
Edwards Lifesciences Corp
28176E108
2057.00000000
NS
USD
178732.73000000
1.421782436189
Long
EC
CORP
US
N
1
N
N
N
Uber Technologies Inc
549300B2FTG34FILDR98
Uber Technologies Inc
90353T100
5337.00000000
NS
USD
344556.72000000
2.740878476857
Long
EC
CORP
US
N
1
N
N
N
CoStar Group Inc
N/A
CoStar Group Inc
22160N109
1779.00000000
NS
USD
139064.43000000
1.106229195249
Long
EC
CORP
US
N
1
N
N
N
Progressive Corp/The
529900TACNVLY9DCR586
Progressive Corp/The
743315103
1537.00000000
NS
USD
324583.66000000
2.581996855652
Long
EC
CORP
US
N
1
N
N
N
Lululemon Athletica Inc
549300D9GZ4BMLDW5T40
Lululemon Athletica Inc
550021109
390.00000000
NS
USD
121676.10000000
0.967908574350
Long
EC
CORP
CA
N
1
N
N
N
Walt Disney Co/The
549300GZKULIZ0WOW665
Walt Disney Co/The
254687106
1248.00000000
NS
USD
129679.68000000
1.031575421886
Long
EC
CORP
US
N
1
N
N
N
NVIDIA Corp
549300S4KLFTLO7GSQ80
NVIDIA Corp
67066G104
876.00000000
NS
USD
960385.08000000
7.639667556817
Long
EC
CORP
US
N
1
N
N
N
Meta Platforms Inc
BQ4BKCS1HXDV9HN80Z93
Meta Platforms Inc
30303M102
839.00000000
NS
USD
391670.37000000
3.115657959467
Long
EC
CORP
US
N
1
N
N
N
Constellium SE
724500KRJEMC79KAAU28
Constellium SE
000000000
5856.00000000
NS
USD
126899.52000000
1.009459815764
Long
EC
CORP
FR
N
1
N
N
N
Intuit Inc
VI90HBPH7XSFMB9E4M29
Intuit Inc
461202103
496.00000000
NS
USD
285914.24000000
2.274389501511
Long
EC
CORP
US
N
1
N
N
N
Boston Scientific Corp
Y6ZDD9FP4P8JSSJMW954
Boston Scientific Corp
101137107
3240.00000000
NS
USD
244846.80000000
1.947706387057
Long
EC
CORP
US
N
1
N
N
N
Dreyfus Institutional Preferred Government Money Market Fund
549300RBWL04JG8SIX57
Dreyfus Institutional Preferred Government Money Market Fund
000000000
124163.57000000
NS
USD
124163.57000000
0.987695891181
Long
STIV
RF
US
N
1
N
N
N
Texas Instruments Inc
WDJNR2L6D8RWOEB8T652
Texas Instruments Inc
882508104
756.00000000
NS
USD
147427.56000000
1.172756189749
Long
EC
CORP
US
N
1
N
N
N
Hologic Inc
549300DYP6F5ZJL0LB74
Hologic Inc
436440101
1816.00000000
NS
USD
133984.48000000
1.065819228442
Long
EC
CORP
US
N
1
N
N
N
Centene Corp
549300Z7JJ4TQSQGT333
Centene Corp
15135B101
2400.00000000
NS
USD
171816.00000000
1.366761258871
Long
EC
CORP
US
N
1
N
N
N
Illumina Inc
SQ95QG8SR5Q56LSNF682
Illumina Inc
452327109
989.00000000
NS
USD
103132.92000000
0.820401357092
Long
EC
CORP
US
N
1
N
N
N
First Horizon Corp
TF3RXI1ZB1TQ30H9JV10
First Horizon Corp
320517105
7739.00000000
NS
USD
122585.76000000
0.975144734234
Long
EC
CORP
US
N
1
N
N
N
ConocoPhillips
WPTL2Z3FIYTHSP5V2253
ConocoPhillips
20825C104
1012.00000000
NS
USD
117877.76000000
0.937693553863
Long
EC
CORP
US
N
1
N
N
N
Progyny Inc
N/A
Progyny Inc
74340E103
5520.00000000
NS
USD
148764.00000000
1.183387297543
Long
EC
CORP
US
N
1
N
N
N
Addus HomeCare Corp
52990090ZT33AKPDBX62
Addus HomeCare Corp
006739106
1152.00000000
NS
USD
132261.12000000
1.052110250913
Long
EC
CORP
US
N
1
N
N
N
Occidental Petroleum Corp
IM7X0T3ECJW4C1T7ON55
Occidental Petroleum Corp
674599105
2773.00000000
NS
USD
173312.50000000
1.378665611340
Long
EC
CORP
US
N
1
N
N
Avantor Inc
N/A
Avantor Inc
05352A100
5402.00000000
NS
USD
130080.16000000
1.034761158656
Long
EC
CORP
US
N
1
N
N
N
Amazon.com Inc
ZXTILKJKG63JELOEG630
Amazon.com Inc
023135106
4280.00000000
NS
USD
755163.20000000
6.007169331642
Long
EC
CORP
US
N
1
N
N
N
2024-07-26
BNY Mellon ETF Trust
James Windels
James Windels
Treasurer
XXXX
NPORT-EX
2
647974BNYM053124.htm
STATEMENT
OF
INVESTMENTS
May
31,
2024
(Unaudited)
Description
Shares
Value
($)
Common
Stocks
–
99.0%
Banks
–
6.3%
Bank
of
America
Corp.
5,483
219,265
First
Horizon
Corp.
7,739
122,586
JPMorgan
Chase
&
Co.
2,252
456,323
798,174
Capital
Goods
–
3.3%
Caterpillar,
Inc.
420
142,178
Trane
Technologies
PLC
848
277,686
419,864
Commercial
&
Professional
Services
–
0.8%
Veralto
Corp.
1,031
101,636
Consumer
Discretionary
Distribution
&
Retail
–
6.0%
Amazon.com,
Inc.
(a)
4,280
755,163
Consumer
Durables
&
Apparel
–
1.0%
Lululemon
Athletica,
Inc.
(a)
390
121,676
Consumer
Services
–
1.8%
Bright
Horizons
Family
Solutions,
Inc.
(a)
2,156
226,639
Energy
–
3.6%
ConocoPhillips
1,012
117,878
Occidental
Petroleum
Corp.
(b)
2,773
173,312
Schlumberger
NV
3,384
155,292
446,482
Financial
Services
–
2.8%
Mastercard,
Inc.,
Class
A
784
350,503
Food,
Beverage
&
Tobacco
–
1.8%
PepsiCo,
Inc.
1,288
222,695
Health
Care
Equipment
&
Services
–
9.3%
Addus
HomeCare
Corp.
(a)
1,152
132,261
Boston
Scientific
Corp.
(a)
3,240
244,847
Centene
Corp.
(a)
2,400
171,816
Cooper
Cos.,
Inc.
(The)
1,652
155,800
Edwards
Lifesciences
Corp.
(a)
2,057
178,733
Hologic,
Inc.
(a)
1,816
133,984
Progyny,
Inc.
(a)
5,520
148,764
1,166,205
Household
&
Personal
Products
–
2.0%
Procter
&
Gamble
Co.
(The)
1,558
256,353
STATEMENT
OF
INVESTMENTS
(continued)
Description
Shares
Value
($)
Common
Stocks
–
99.0%
(continued)
Insurance
–
2.6%
Progressive
Corp.
(The)
1,537
324,584
Materials
–
1.0%
Constellium
SE
(a)
5,856
126,900
Media
&
Entertainment
–
5.2%
Meta
Platforms,
Inc.,
Class
A
839
391,670
Pinterest,
Inc.,
Class
A
(a)
3,204
132,934
Walt
Disney
Co.
(The)
1,248
129,680
654,284
Pharmaceuticals,
Biotechnology
&
Life
Sciences
–
9.6%
AbbVie,
Inc.
2,158
347,956
Alnylam
Pharmaceuticals,
Inc.
(a)
480
71,247
Avantor,
Inc.
(a)
5,402
130,080
Eli
Lilly
&
Co.
410
336,339
Illumina,
Inc.
(a)
989
103,133
Natera,
Inc.
(a)
668
71,162
Zoetis,
Inc.,
Class
A
868
147,178
1,207,095
Real
Estate
Management
&
Development
–
1.1%
CoStar
Group,
Inc.
(a)
1,779
139,064
Semiconductors
&
Semiconductor
Equipment
–
11.8%
LAM
Research
Corp.
168
156,650
Micron
Technology,
Inc.
1,757
219,625
NVIDIA
Corp.
876
960,385
Texas
Instruments,
Inc.
756
147,428
1,484,088
Software
&
Services
–
20.0%
Accenture
PLC,
Class
A
761
214,823
Akamai
Technologies,
Inc.
(a)
1,517
139,928
HubSpot,
Inc.
(a)
394
240,754
Intuit,
Inc.
496
285,914
Microsoft
Corp.
2,646
1,098,434
PTC,
Inc.
(a)
658
115,966
Shopify,
Inc.,
Class
A
(a)
4,488
265,465
Workday,
Inc.,
Class
A
(a)
720
152,244
2,513,528
Technology
Hardware
&
Equipment
–
3.1%
Apple,
Inc.
2,054
394,881
Transportation
–
4.1%
FedEx
Corp.
655
166,344
Uber
Technologies,
Inc.
(a)
5,337
344,557
510,901
See
Notes
to
Statement
of
Investments
Description
Shares
Value
($)
Common
Stocks
–
99.0%
(continued)
Utilities
–
1.8%
Dominion
Energy,
Inc.
4,163
224,469
Total
Common
Stocks
(cost
$9,960,319)
12,445,184
Investment
Companies
–
1.0%
Registered
Investment
Companies
–
1.0%
Dreyfus
Institutional
Preferred
Government
Money
Market
Fund,
Institutional
Shares,
5.28%
(c)(d)
(cost
$124,164)
124,164
124,164
Total
Investments
(cost
$10,084,483)
100.0%
12,569,348
Cash
and
Receivables
(Net)
0.0%
1,684
Net
Assets
100.0%
12,571,032
(a)
Non-income
producing
security.
(b)
Security,
or
portion
thereof,
on
loan.
At
May
31,
2024,
the
value
of
the
fund’s
securities
on
loan
was
$171,563
and
the
value
of
the
collateral
was
$171,871,
consisting
of
U.S.
Government
&
Agency
securities.
In
addition,
the
value
of
collateral
may
include
pending
sales
that
are
also
on
loan.
(c)
Investment
in
affiliated
issuer.
The
investment
objective
of
this
investment
company
is
publicly
available
and
can
be
found
within
the
investment
company’s
prospectus.
(d)
The
rate
shown
is
the
1-day
yield
as
of
May
31,
2024.
NOTES
TO
STATEMENT
OF
INVESTMENTS
(Unaudited)
The
Financial
Accounting
Standards
Board
(“FASB”)
Accounting
Standards
Codification
(“ASC”)
is
the
exclusive
reference
of
authoritative
U.S.
generally
accepted
accounting
principles
(“GAAP”)
recognized
by
the
FASB
to
be
applied
by
nongovernmental
entities.
Rules
and
interpretive
releases
of
the
Securities
and
Exchange
Commission
(“SEC”)
under
authority
of
federal
laws
are
also
sources
of
authoritative
GAAP
for
SEC
registrants. BNY
Mellon
Women's
Opportunities
ETF (the
“fund”)
is an
investment
company
and
applies
the
accounting
and
reporting
guidance
of
the
FASB
ASC
Topic
946
Financial
Services-Investment
Companies. The
fund’s
financial
statements
are
prepared
in
accordance
with
GAAP,
which
may
require
the
use
of
management
estimates
and
assumptions.
Actual
results
could
differ
from
those
estimates.
(a)
Portfolio
valuation:
The
fair
value
of
a
financial
instrument
is
the
amount
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
at
the
measurement
date
(i.e.,
the
exit
price).
GAAP
establishes
a
fair
value
hierarchy
that
prioritizes
the
inputs
of
valuation
techniques
used
to
measure
fair
value.
This
hierarchy
gives
the
highest
priority
to
unadjusted
quoted
prices
in
active
markets
for
identical
assets
or
liabilities
(Level
1
measurements)
and
the
lowest
priority
to
unobservable
inputs
(Level
3
measurements).
Additionally,
GAAP
provides
guidance
on
determining
whether
the
volume
and
activity
in
a
market
has
decreased
significantly
and
whether
such
a
decrease
in
activity
results
in
transactions
that
are
not
orderly.
GAAP
requires
enhanced
disclosures
around
valuation
inputs
and
techniques
used
during
annual
and
interim
periods.
Various
inputs
are
used
in
determining
the
value
of
the
fund’s
investments
relating
to
fair
value
measurements.
These
inputs
are
summarized
in
the
three
broad
levels
listed
below:
Level
1
—
unadjusted
quoted
prices
in
active
markets
for
identical
investments.
Level
2
—
other
significant
observable
inputs
(including
quoted
prices
for
similar
investments,
interest
rates,
prepayment
speeds,
credit
risk,
etc.).
Level
3
—
significant
unobservable
inputs
(including
the
fund’s
own
assumptions
in
determining
the
fair
value
of
investments).
The
inputs
or
methodology
used
for
valuing
securities
are
not
necessarily
an
indication
of
the
risk
associated
with
investing
in
those
securities.
Changes
in
valuation
techniques
may
result
in
transfers
in
or
out
of
an
assigned
level
within
the
disclosure
hierarchy.
Valuation
techniques
used
to
value
the
fund’s
investments
are
as
follows:
BNY
Mellon
ETF
Trust’s
(the
“Trust”) Board
of
Trustees
(the
“Board”)
has
designated
the
Adviser
as
the
fund’s
valuation
designee
to
make
all
fair
value
determinations
with
respect
to
the
fund’s
portfolio
of
investments,
subject
to
the
Board’s
oversight
and
pursuant
to
Rule
2a-5
under
the
Act.
Investments
in
equity
securities,
including
ETFs
(but
not
including
investments
in
other
open-end
registered
investment
companies),
generally
are
valued
at
the
last
sales
price
on
the
day
of
valuation
on
the
securities
exchange
or
national
securities
market
on
which
such
securities
primarily
are
traded.
Securities
listed
on
the
National
Association
of
Securities
Dealers
Automated
Quotation
System
(“NASDAQ”)
for
which
market
quotations
are
available
will
be
valued
at
the
official
closing
price.
If
there
are
no
transactions
in
a
security,
or
no
official
closing
prices
for
a
NASDAQ
market-listed
security
on
that
day,
the
security
will
be
valued
at
the
average
of
the
most
recent
bid
and
asked
prices.
Bid
price
is
used
when
no
asked
price
is
available.
Open
short
positions
for
which
there
is
no
sale
price
on
a
given
day
are
valued
at
the
lowest
asked
price.
Registered
investment
companies
that
are
not
traded
on
an
exchange
are
valued
at
their
net
asset
value.
All
of
the
preceding
securities
are
generally
categorized
within
Level
1
of
the
fair
value
hierarchy.
When
market
quotations
or
official
closing
prices
are
not
readily
available,
or
are
determined
not
to
reflect
fair
value
accurately,
they are
valued
at
fair
value
as
determined
in
good
faith
based
on
procedures
approved
by
the
Board.
Fair
value
of
investments
may
be
determined
by
valuation
designee
using
such
information
as
it
deems
appropriate
under
the
circumstances.
Certain
factors
may
be
considered
when
fair
valuing
investments
such
as:
fundamental
analytical
data,
the
nature
and
duration
of
restrictions
on
disposition,
an
evaluation
of
the
forces
that
influence
the
market
in
which
the
securities
are
purchased
and
sold,
and
public
trading
in
similar
securities
of
the
issuer
or
comparable
issuers.
These
securities
are
either
categorized
within
Level
2
or
3
of
the
fair
value
hierarchy
depending
on
the
relevant
inputs
used.
For
securities
where
observable
inputs
are
limited,
assumptions
about
market
activity
and
risk
are
used
and
are
generally
categorized
within
Level
3
of
the
fair
value
hierarchy.
The
table
below
summarizes
the
inputs
used
as
of May
31,
2024
in
valuing
the
fund’s
investments:
NOTES
TO
STATEMENT
OF
INVESTMENTS
(Unaudited)
(continued)
Fair
Value
Measurements
Pursuant
to
a
securities
lending
agreement
with
BNY
Mellon,
the
fund
may
lend
securities
to
qualified
institutions.
It
is
the
fund’s
policy
that,
at
origination,
all
loans
are
secured
by
collateral
of
at
least
102%
of
the
value
of
U.S.
securities
loaned
and
105%
of
the
value
of
foreign
securities
loaned.
Collateral
equivalent
to
at
least
100%
of
the
market
value
of
securities
on
loan
is
maintained
at
all
times.
Collateral
is
either
in
the
form
of
cash,
which
can
be
invested
in
certain
money
market
mutual
funds
managed
by
the
Adviser,
or
U.S.
Government
and
Agency
securities.
The
fund
is
entitled
to
receive
all
dividends,
interest
and
distributions
on
securities
loaned,
in
addition
to
income
earned
as
a
result
of
the
lending
transaction.
Should
a
borrower
fail
to
return
the
securities
in
a
timely
manner,
The
Bank
of
New
York
Mellon
is
required
to
replace
the
securities
for
the
benefit
of
the
fund
or
credit
the
fund
with
the
market
value
of
the
unreturned
securities
and
is
subrogated
to
the
fund’s
rights
against
the
borrower
and
the
collateral.
Additionally,
the
contractual
maturity
of
security
lending
transactions
are
on
an
overnight
and
continuous
basis.
Additional
investment
related
disclosures
are
hereby
incorporated
by
reference
to
the
annual
and
semi-annual
reports
previously
filed
with
the
SEC
on
Form
N-CSR.
At May
31,
2024,
accumulated
net
unrealized
appreciation on
investments
was
$2,484,865,
consisting
of
gross
appreciation
of
$2,791,781
and
gross
depreciation
of
$306,916.
At
May
31,
2024,
the
cost
of
investments
for
federal
income
tax
purposes
was
substantially
the
same
as
the
cost
for
financial
reporting
purposes
(see
the
Statement
of
Investments).
Level
1
-
Unadjusted
Quoted
Prices
Level
2
-
Other
Significant
Observable
Inputs
Level
3
-
Significant
Unobservable
Inputs
Total
Assets
($)
Investments
In
Securities:
†
Common
Stocks
12,445,184
—
—
12,445,184
Investment
Companies
124,164
—
—
124,164
†
See
Statement
of
Investments
for
additional
detailed
categorizations,
if
any.